# Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

> clinical trial · VERIFIED · 2026-08-14

Status: RECRUITING · Sponsor: Dyne Therapeutics · Condition: Myotonic Dystrophy Type 1 (DM1)

- Company: Dyne Therapeutics
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07486934

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.